Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Binder

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 27, 2005
Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up studyPrimus E Mullis, Iain C A F Robinson, Souzan Salemi, et al.
Deutsche Medizinische Wochenschrift (1946)|March 16, 2019
[Life Situation of Young women with Turner Syndrome: Results of a Questionnaire-based Study in Germany]Helmuth-Günther Dörr, Markus Bettendorf, Gerhard Binder, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformityGerhard Binder, Alexandra Renz, Alicia Martinez, et al.
EMBO Molecular Medicine|November 19, 2016
Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiencyAntonino Montalbano, Lonny Juergensen, Ralph Roeth, et al.
Deutsche Medizinische Wochenschrift (1946)|July 25, 2019
[Medical care of young women with Turner syndrome in Germany]Helmuth-Günther Dörr, Markus Bettendorf, Gerhard Binder, et al.
Endocrine Connections|September 5, 2022
Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectivesDanielle Christine Maria van der Kaay, Anne Rochtus, Gerhard Binder, et al.
Plos One|March 12, 2016
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding FactorsFelix P Bernhard, Sebastian Heinzel, Gerhard Binder, et al.
Molecular and Cellular Pediatrics|July 11, 2020
Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiencyHelmuth-Günther Dörr, Nadja Schulze, Markus Bettendorf, et al.
Hormone Research in Paediatrics|May 11, 2012
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature)Janina Caliebe, Sander Broekman, Merel Boogaard, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinantsMaki Fukami, Makio Shozu, Shun Soneda, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|January 27, 2005
Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up studyPrimus E Mullis, Iain C A F Robinson, Souzan Salemi, et al.
Deutsche Medizinische Wochenschrift (1946)|March 16, 2019
[Life Situation of Young women with Turner Syndrome: Results of a Questionnaire-based Study in Germany]Helmuth-Günther Dörr, Markus Bettendorf, Gerhard Binder, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformityGerhard Binder, Alexandra Renz, Alicia Martinez, et al.
EMBO Molecular Medicine|November 19, 2016
Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiencyAntonino Montalbano, Lonny Juergensen, Ralph Roeth, et al.
Deutsche Medizinische Wochenschrift (1946)|July 25, 2019
[Medical care of young women with Turner syndrome in Germany]Helmuth-Günther Dörr, Markus Bettendorf, Gerhard Binder, et al.
Endocrine Connections|September 5, 2022
Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectivesDanielle Christine Maria van der Kaay, Anne Rochtus, Gerhard Binder, et al.
Plos One|March 12, 2016
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding FactorsFelix P Bernhard, Sebastian Heinzel, Gerhard Binder, et al.
Molecular and Cellular Pediatrics|July 11, 2020
Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiencyHelmuth-Günther Dörr, Nadja Schulze, Markus Bettendorf, et al.
Hormone Research in Paediatrics|May 11, 2012
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature)Janina Caliebe, Sander Broekman, Merel Boogaard, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinantsMaki Fukami, Makio Shozu, Shun Soneda, et al.
Pageof 13